0001973141-24-000021.txt : 20240108 0001973141-24-000021.hdr.sgml : 20240108 20240108160502 ACCESSION NUMBER: 0001973141-24-000021 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240108 DATE AS OF CHANGE: 20240108 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Intellia Therapeutics, Inc. CENTRAL INDEX KEY: 0001652130 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 364785571 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-37766 FILM NUMBER: 24520058 BUSINESS ADDRESS: STREET 1: 40 ERIE STREET STREET 2: SUITE 130 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-285-6200 MAIL ADDRESS: STREET 1: 40 ERIE STREET STREET 2: SUITE 130 CITY: CAMBRIDGE STATE: MA ZIP: 02139 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Sepp-Lorenzino Laura CENTRAL INDEX KEY: 0001777421 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O INTELLIA THERAPEUTICS, INC. STREET 2: 40 ERIE STREET, SUITE 130 CITY: CAMBRIDGE STATE: MA ZIP: 02139 144 1 primary_doc.xml 144 0001777421 XXXXXXXX LIVE 0001652130 Intellia Therapeutics, Inc. 001-37766 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200 Sepp-Lorenzino Laura Officer Common UBS Financial Services, Inc.

1000 Harbor Blvd 3rd Floor Weehawken NJ 07086

2275 64109.00 89554891 01/08/2024 NASDAQ Common 01/01/2024 Restricted Stock Unit Issuer N 2275 01/01/2024 N/A Y 01/08/2024 03/14/2023 /s/ UBS Financial Services Inc, as attorney-in-fact for Laura Sepp-Lorenzino